Latest Lewy body Stories
FINDINGS: Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity, a hallmark of Parkinson's disease.
NEW YORK, Dec. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced $1.7 million in funding to drive new and continuing Parkinson's research projects at the Banner Sun Health Research Institute and Mayo Clinic Arizona, sites of the Arizona Parkinson's Disease Consortium.
Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease.
NEW YORK, Sept.
Accumulation of the synaptic protein alpha-synuclein, resulting in the formation of aggregates called Lewy bodies in the brain, is a hallmark of Parkinson's and other related neurodegenerative diseases.
Mayo Clinic researchers plan to present a study on new techniques to diagnose dementia at a conference in Vienna, the clinic announced Saturday. Researchers developed a framework for using an MRI to create a differential diagnosis of three common neurodegenerative disorders.
KIRKLAND, Wash., Feb 26 /PRNewswire/ -- ProteoTech Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Disease Research. In collaboration with Avid Radiopharmaceuticals Inc.
NEW YORK, Feb. 18 /PRNewswire-USNewswire/ -- The Michael J.
Neurologists have observed for decades that Lewy bodies, clumps of aggregated proteins inside cells, appear in the brains of patients with Parkinson's disease and other neurodegenerative diseases.
CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease.
- Emitting flashes of light; glittering.